Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)

China · Delayed Price · Currency is CNY

65.56

-4.47 (-6.38%)

At close: Mar 23, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2015
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '15 Dec 31, 2015
Pharmaceutical Production and Sales Business	4.20B	1.19B	1.01B	825.49M	928.81M
Pharmaceutical Production and Sales Business Growth	251.81%	17.70%	22.84%	-11.12%	41.80%
Total	4.20B	1.19B	1.01B	825.49M	928.81M
Total Growth	251.81%	17.70%	22.84%	-11.12%	41.80%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '15 Dec 31, 2015
Mainland China	1.18B	-	-	-
Other Countries and Regions	9.24M	-	-	-
Total	1.19B	-	-	-

Source: S&P Global Market Intelligence.